Dual‐Task Gait Cognitive‐Motor Interference as a Marker of Cognitive Impairment in Parkinson's Disease: A Systematic Review and Meta‐Analysis
Movement Disorders Clinical Practice · 2026-04 · 13 (4) · 876-888
DOI: 10.1002/mdc3.70409 ↗At a glance
Systematische Übersicht in Movement Disorders Clinical Practice, published online on 2025-11-01. Written by Samwel Sylvester Msigwa and 5 co-authors. Institution: Department of Neurology, Institute of Geriatric Neurology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University,…. Major MEDLINE topics: Parkinson Disease, Cognitive Dysfunction, Gait, Gait Disorders, Neurologic. Cited 6 times so far (Crossref); 65 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Cognitive impairment in Parkinson's disease (PD‐CI) negatively affects mobility, independence, and quality of life. Dual‐task (DT) gait testing, which captures cognitive–motor interference (CMI), has emerged as a promising, non‐invasive method to detect PD‐CI.
Objective
This systematic review and meta‐analysis assessed the sensitivity of DT gait parameters—including stride length, gait speed, cadence, variability, and Timed Up and Go (TUG)—in differentiating PD‐CI from cognitively normal PD (PD‐NC), and examined subgroup differences between mild cognitive impairment (PD‐MCI) and subjective cognitive decline (PD‐SCD).
Methods
PubMed, Web of Science, and Embase were searched for observational studies comparing DT gait in PD‐CI versus PD‐NC. Random‐effects meta‐analyses estimated pooled effect sizes (Hedges’ g ), with subgroup and meta‐regression analyses exploring task‐ and disease‐related moderators.
Results
DT stride length showed the largest impairment in PD‐CI ( g = −0.994, P < 0.001), followed by TUG ( g = +0.850, P = 0.001), gait speed ( g = −0.542, P = 0.001), cadence ( g = −0.370, P = 0.002), and stride variability ( g = +0.590, P < 0.001). Subgroup analyses indicated DT gait speed reliably differentiated PD‐MCI from PD‐NC ( g = −0.59, P < 0.001), but not PD‐SCI from other groups. Meta‐regression showed shorter disease duration (≤5 years) and lower Hoehn & Yahr stage (
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Neurology, Institute of Geriatric Neurology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
- Department of Psychiatry and Mental Health, School of Medicine and Dentistry, The University of Dodoma, Dodoma, Tanzania.
- Department of Neurology, Mirembe National Mental Health Hospital, Dodoma, Tanzania.
- Department of Oncology, Ludwig Maximilian University of Munich, Munchen, Germany.
- Department of Pediatrics, Zhongnan Hospital of Wuhan University, Wuhan, China.
- School of Medicine and Dentistry, The University of Dodoma, Dodoma, Tanzania.
ORCID profiles: Samwel Sylvester Msigwa, Jian-Yong Wang
Cite
APA
Msigwa, S. S., Hong, S., Mkwambe, M. C., Marealle, E., Zhang, X., & Wang, J. Y. (2026). Dual‐Task Gait Cognitive‐Motor Interference as a Marker of Cognitive Impairment in Parkinson's Disease: A Systematic Review and Meta‐Analysis. Movement Disorders Clinical Practice, 13(4), 876-888. https://doi.org/10.1002/mdc3.70409
Vancouver
Msigwa SS, Hong S, Mkwambe MC, Marealle E, Zhang X, Wang JY. Dual‐Task Gait Cognitive‐Motor Interference as a Marker of Cognitive Impairment in Parkinson's Disease: A Systematic Review and Meta‐Analysis. Movement Disorders Clinical Practice. 2026;13(4):876-888. doi:10.1002/mdc3.70409
BibTeX
@article{Msigwa2026,
author = {Msigwa, Samwel Sylvester and Hong, Shuang and Mkwambe, Maiko Charles and Marealle, Elizabeth and Zhang, Xiong and Wang, Jian-Yong},
title = {Dual‐Task Gait Cognitive‐Motor Interference as a Marker of Cognitive Impairment in Parkinson's Disease: A Systematic Review and Meta‐Analysis},
journal = {Movement Disorders Clinical Practice},
year = {2026},
volume = {13},
number = {4},
pages = {876--888},
doi = {10.1002/mdc3.70409}
}
EUVIMED